Rehabilitation Program for People With Methamphetamine-Associated Cardiopulmonary Conditions
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to evaluate the feasibility and preliminary effectiveness of increasing control over stimulant use and physical health through incentivized rehabilitation (INSPIRE). INSPIRE is a 12-week remotely-delivered collaborative care intervention for rural patients with Methamphetamine-Associated Heart Failure (Me-HF) or Methamphetamine-Associated Pulmonary Arterial Hypertension (Me-PAH) featuring smartphone-based contingency management incentivizing participation in remote synchronous rehabilitation.
Sponsor: Michael Incze
You may qualify if…
- ✓ Active methamphetamine use determined by positive urine drug testing within the past 3 months and/or self-reported current use
- ✓ Current diagnosis of chronic heart failure or pulmonary hypertension documented in the electronic health record
- ✓ Possession of a smartphone
- ✓ Able to participate in virtual exercise rehabilitation
You may not qualify if…
- ✕ Currently incarcerated
- ✕ Unable to interact with smartphone app and/or virtual health coaching sessions in English
- ✕ Unstable arrhythmia, defined as any known arrhythmia that is associated with hemodynamic effects like syncope, hypotension, or decompensated heart failure
- ✕ Decompensated chronic heart failure or pulmonary hypertension
- ✕ NYHA class IV symptoms
- ✕ Myocardial infarction within the past 3 months, percutaneous coronary intervention within the past 2 weeks, coronary artery bypass graft within the past 3 months, or implantable cardiac defibrillator/cardiac resynchronization therapy/pacemaker implantation within the last 6 weeks
- ✕ Unstable angina, uncontrolled hypertension, acute myocarditis/pericarditis, intracardiac thrombus
- ✕ Severe symptomatic aortic stenosis
Where it's recruiting
Salt Lake City
Source: ClinicalTrials.gov · NCT07915882 · last updated 2026-11-04